Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy
Preprint in bioRxiv (March 2024)
The most recent citing publications are shown below. View all 91 publications that cite this research output on Dimensions.
Preprint in bioRxiv (March 2024)
Article in Expert Review of Anticancer Therapy (March 2024)
Article in Frontiers in Oncology (October 2023)